{
    "paper_id": "94911e2cb4c082fea75d81778ba059f7fa42c914",
    "metadata": {
        "title": "Parallel Session 33: Alcoholic Liver Disease Hynes Convention Center Room 311 THE ACUTE ALCOHOLIC HEPATITIS SCORING SYSTEM (GLASGOW) IMPROVES THE PREDICTION OF SHORT AND MEDIUM-TERM MORTALITY SAFETY AND POTENTIAL EFFICACY OF ETANERCEPT IN PATIENTS WITH ALCOHOLIC HEPATITIS: ANALYSIS OF A RECENTLY COMPLETED PILOT STUDY A RANDOMIZED PLACEBO CONTROLLED TRIAL OF VITAMIN E IN ALCOHOLIC HEPATITIS SPHINGOSIN 1-PHOSPHATE (SIP) INDUCES INCREASE IN INTRACELLULAR CA2+ AND NITRIC OXIDE (NO) FORMATION, BUT NOT PROTEIN KINASE B (PKB)/AKT ACTIVATION IN RAT LIVER SINUSOIDAL ENDOTHELIAL CELLS: POSSIBLE MECHANISMS OF SIP FOR SINUSOIDAL PROTECTION AGAINST ETHANOL-INDUCED INJURY TRANSGENIC MICE FED ETHANOL INTRAGASTRICALLY FOR 4 WEEKS 12:30pm Parallel Session 34: Clinical and Epidemiologic Advances in Chronic Liver Disease HEPATITIS C VIRUS REINFECTION WITHIN A COHORT OF INJECTING DRUG USERS A COMPREHENSIVE STUDY OF HEPATITIS C VIRUS PREVALENCE AND RISK FACTORS IN THE INCARCERATED SETTING: INMATES, PAROLEES AND PRISON WORKERS IN CALIFORNIA STATE CORRECTIONS 12:15pm # 233 STEATOSIS IN CHRONIC HEPATITIS B AND C: PREDICTORS, DISTRIBUTION AND EFFECT ON FIBROSIS Parallel Session 35: Drug Metabolism and Toxicity 11:15am # 235 OXYGEN MODULATION OF CYTOCHROME P450 PATHWAYS: ROLE OF OXYGEN GRADIENTS AND HIF-1ALPHA IN HEPATOCYTES IN VITRO HIGH FREQUENCY OF SINGLE NUCLEOTIDE POLY- MORPHISMS (SNPS) AT THE HUMAN UGTIA GENE LOCUS: DIFFERENTIAL ALTERATIONS OF GLUCURONIDATION OF TWO NOVEL SNPS OF THE HEPATIC UGTIA4 GENE",
        "authors": [
            {
                "first": "",
                "middle": [],
                "last": "74a Aasld Program",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "",
                "middle": [],
                "last": "Hepatology",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [
        {
            "text": "publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. ~0 <rr am ~m mO D",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "Those posters identified as AASLD Presidential Poster of Distinction by a ribbon icon have received review scores that place them within the top 10% of all posters. We encourage you to make them a priority as you visit the poster session. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        }
    ],
    "bib_entries": {
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Western Attica General Hospital",
            "authors": [
                {
                    "first": "Nickolas",
                    "middle": [],
                    "last": "Tassopoulos",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Henry Dunant Hospital",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "UK # 1161 SPECIFIC INHIBITION OF HEPATITIS B VIRUS BY LENTI-VIRAL VECTOR DELIVERED HAMMERHEAD RIBOZYMES",
            "authors": [
                {
                    "first": "V",
                    "middle": [],
                    "last": "Nikolai",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Naoumov",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "GH Piti6-Salp6tri6re",
            "authors": [
                {
                    "first": "Olivier",
                    "middle": [],
                    "last": "Lada",
                    "suffix": ""
                },
                {
                    "first": "Yves",
                    "middle": [],
                    "last": "Berdlamou",
                    "suffix": ""
                },
                {
                    "first": "Marc",
                    "middle": [
                        "Antoine"
                    ],
                    "last": "Valantin",
                    "suffix": ""
                },
                {
                    "first": "Christine",
                    "middle": [],
                    "last": "Katlama",
                    "suffix": ""
                },
                {
                    "first": "Thierry",
                    "middle": [],
                    "last": "Poynard",
                    "suffix": ""
                },
                {
                    "first": "Annie",
                    "middle": [],
                    "last": "Cahour",
                    "suffix": ""
                },
                {
                    "first": "Vincent",
                    "middle": [],
                    "last": "Thibault",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "# 1168 INHIBITORY EFFECT OF ADEFOVIR AND LAMIVUDINE ON THE INITIATION OF HEPATITIS B VIRUS INFECTION IN PRIMARY TUPAIA HEPATOCYTES Josef KOck",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Lynette L E Oon",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Hospital",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Singapore",
                    "suffix": ""
                },
                {
                    "first": ";",
                    "middle": [],
                    "last": "Singapore",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Christopher",
                    "suffix": ""
                },
                {
                    "first": "University",
                    "middle": [],
                    "last": "Sherlock",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Of British",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Columbia",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Vancouver",
                    "suffix": ""
                },
                {
                    "first": "Canada; Jeffrey",
                    "middle": [],
                    "last": "Bc",
                    "suffix": ""
                },
                {
                    "first": "Mayo",
                    "middle": [],
                    "last": "Germer",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Clinic",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Rochester",
                    "suffix": ""
                },
                {
                    "first": ";",
                    "middle": [],
                    "last": "Mn; Sandra Menting",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Vancouver",
                    "suffix": ""
                },
                {
                    "first": "Canada; Rainer",
                    "middle": [],
                    "last": "Bc",
                    "suffix": ""
                },
                {
                    "first": "Johan",
                    "middle": [],
                    "last": "Ziermann",
                    "suffix": ""
                },
                {
                    "first": "James",
                    "middle": [],
                    "last": "Surtihadi",
                    "suffix": ""
                },
                {
                    "first": "Bayer",
                    "middle": [],
                    "last": "Hnatyszyn",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Healthcare",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Berkeley",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Antisense Rna-Mediated",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Inhibition",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Hepatitis B Virus Kathryn",
                    "suffix": ""
                },
                {
                    "first": "Graeme",
                    "middle": [
                        "J"
                    ],
                    "last": "Nash",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Alexander",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Andrew",
                    "suffix": ""
                },
                {
                    "first": ";",
                    "middle": [],
                    "last": "Lever",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Thomas",
                    "suffix": ""
                },
                {
                    "first": "Hubert",
                    "middle": [
                        "E"
                    ],
                    "last": "Baumert",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Blum",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "# 1170 KINETICS OF VIRAL RESISTANCE AND SERUM HBV DNA IN PATIENTS UNDERLAMIVUDINE THERAPY Michelle Martinot Peignoux, INSERM U481",
            "authors": [
                {
                    "first": "Case-Control Study Of Lamivudine Treatment In Patients With Hbv-Related",
                    "middle": [],
                    "last": "Hepatocellular Carcinoma Shin-Ichi Fujioka",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "Mich61e Pouteau, Service d'H6patologie, H6pital Beaujon",
            "authors": [
                {
                    "first": "Anne",
                    "middle": [],
                    "last": "Gervais",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Service D&apos;hdpatologie",
                    "suffix": ""
                },
                {
                    "first": "France; Corinne",
                    "middle": [],
                    "last": "Clichy",
                    "suffix": ""
                },
                {
                    "first": "Nathalie",
                    "middle": [],
                    "last": "Castelnau",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Boyer",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "# 1171 MOLECULAR EPIDEMIOLOGY OF HEPATITIS B VIRUS IN PATIENTS WITH HBEAG-NEGATIVE/ANTI-HBE-POSITIVE CHRONIC HEPATITIS B FROM DIFFERENT GEOGRAPHICAL AREAS. DATA FROM THE PEGASYS\u00ae STUDY IN HBE-ANTIGEN-NEGATIVE CHB",
            "authors": [
                {
                    "first": "Clichy",
                    "middle": [],
                    "last": "Beaujon",
                    "suffix": ""
                },
                {
                    "first": "France; Patrick",
                    "middle": [],
                    "last": "Marcellin",
                    "suffix": ""
                },
                {
                    "first": "H(spital",
                    "middle": [],
                    "last": "Service D&apos;hdpatologie",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Beaujon",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "# 1173 COMBINATION THERAPY USING INTERFERON AND LAMIVUDINE IN PEDIATRIC PATIENTS WITH HEPATITIS B",
            "authors": [
                {
                    "first": "Ulrike",
                    "middle": [],
                    "last": "Mihm",
                    "suffix": ""
                },
                {
                    "first": ";",
                    "middle": [],
                    "last": "Homburg",
                    "suffix": ""
                },
                {
                    "first": "Germany; Christina Maria",
                    "middle": [],
                    "last": "Jung",
                    "suffix": ""
                },
                {
                    "first": "Klinikum",
                    "middle": [],
                    "last": "Ludwig-Maximillian-Universit~t",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Der Universitat-Grot~hadern",
                    "suffix": ""
                },
                {
                    "first": "Germany; Christoph",
                    "middle": [],
                    "last": "/Inchen",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Sarrazin",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "New York Presbyterian Hospital--Columbia",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Steven",
                    "suffix": ""
                },
                {
                    "first": "Patricia",
                    "middle": [],
                    "last": "Lobritto",
                    "suffix": ""
                },
                {
                    "first": "Yvette",
                    "middle": [],
                    "last": "Harren",
                    "suffix": ""
                },
                {
                    "first": "Robert",
                    "middle": [
                        "S"
                    ],
                    "last": "Sims",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Brown",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "# 1174 DETECTION OF HEPATITIS B VIRUS VARIANTS ASSOCIATED WITH LAMIVUDINE RESISTANCE USING MASS SPECTROMETRIC ANALYSIS Seong-Gyu Hwang",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "Infectious Diseases Hospital",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Tsekoura",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Ioannidis",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Vasiliadou",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Mamasi",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Chrysagis",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Greece # 1176 A SENSITIVE, QUANTITATIVE REAL-TIME PCR ASSAY TO DETECT LAMIVUDINE RESISTANCE-ASSOCIATED MUTATIONS IN HEPATITIS B VIRUS",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF31": {
            "ref_id": "b31",
            "title": "~0 ~ Pd #1178 I1",
            "authors": [
                {
                    "first": "Noboru",
                    "middle": [],
                    "last": "Hirashima",
                    "suffix": ""
                },
                {
                    "first": "Chukyo",
                    "middle": [],
                    "last": "Hospital",
                    "suffix": ""
                },
                {
                    "first": "Japan; Motokazu",
                    "middle": [],
                    "last": "Nagoya",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Mukaide",
                    "suffix": ""
                },
                {
                    "first": "Inc",
                    "middle": [],
                    "last": "Srl",
                    "suffix": ""
                },
                {
                    "first": "Japan; Tatsuya",
                    "middle": [],
                    "last": "Hachiouji",
                    "suffix": ""
                },
                {
                    "first": "Michio",
                    "middle": [],
                    "last": "Ide",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Sara ; Ryuzo",
                    "suffix": ""
                },
                {
                    "first": "Masashi",
                    "middle": [],
                    "last": "Ueda",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Mizokami",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF32": {
            "ref_id": "b32",
            "title": "# 1179 HEPATITIS B VIRUS GENOTYPES B AND C DO NOT AFFECT THE ANTI-VIRAL RESPONSE TO LAMIVUDINE Man-Fung Yuen",
            "authors": [
                {
                    "first": "D W Effect",
                    "middle": [],
                    "last": "Of",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Precore",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "On",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Viral",
                    "suffix": ""
                },
                {
                    "first": "; Therapy In Hbeag-Positive Chronic Hepatitis B D F-I--O Sun Suk",
                    "middle": [],
                    "last": "During Lamivudine Ifl",
                    "suffix": ""
                },
                {
                    "first": "Yu",
                    "middle": [
                        "Jin"
                    ],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "Kwang",
                    "middle": [
                        "An"
                    ],
                    "last": "Hwang",
                    "suffix": ""
                },
                {
                    "first": "Moon",
                    "middle": [
                        "Gi"
                    ],
                    "last": "Kwon",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Jung",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Dong Kyun",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Park",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "Hong Kong # 1180 ALT FLARES IN PATIENTS WITH HBEAG-POSITIVE CHRONIC HEPATITIS B AND TREATED WITH EITHER CONVENTIONAL INTERFERON ALFA-2A OR PEGINTERFERON ALFA-2A (40KD) (PEGASYS\u00ae) ARE NOT NECESSARY FOR A SIGNIFICANT RESPONSE TO THERAPY",
            "authors": [
                {
                    "first": "Erwin",
                    "middle": [],
                    "last": "Sablon",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "V"
                    ],
                    "last": "Innogenetics",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Ghent",
                    "suffix": ""
                },
                {
                    "first": "Siu-Man",
                    "middle": [],
                    "last": "Belgium; He-Jun Yuan",
                    "suffix": ""
                },
                {
                    "first": "Chee-Kin",
                    "middle": [],
                    "last": "Sum",
                    "suffix": ""
                },
                {
                    "first": "Benjamin Chun-Yu",
                    "middle": [],
                    "last": "Hui",
                    "suffix": ""
                },
                {
                    "first": "Ching-Lung",
                    "middle": [],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "; W Graham E Cooksley ; Yuan-Jen",
                    "middle": [],
                    "last": "Lai",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "# 1181 A PHASE III, PARTIALLY DOUBLE-BLINDED STUDY EVALU-ATING THE EFFICACY AND SAFETY OF PEGINTERFERON ALFA-2A (40KD) (PEGASYS\u00ae) ALONE OR IN COMBINATION WITH LAMIVUDINE VS LAMIVUDINE IN 546 PATIENTS WITH HBEAG-NEGATIVE/ANTI-HBE-POSITIVE CHRONIC HEPATITIS B Patrick Marcellin, H6pital Beaujon",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF36": {
            "ref_id": "b36",
            "title": "Teerha Piratvisuth, Songklanakarin Hospital Songkla, Thailand; Georgios Germanidis",
            "authors": [
                {
                    "first": "Patrizia",
                    "middle": [],
                    "last": "Farci",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "University Of Cagliari",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Cagliari",
                    "suffix": ""
                },
                {
                    "first": "Henry",
                    "middle": [
                        "Dunant"
                    ],
                    "last": "Hadziyannis",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Hospital",
                    "suffix": ""
                },
                {
                    "first": "Greece; Rui Jin ; Zhi-Meng",
                    "middle": [],
                    "last": "Athens",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Lu",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "NAIVE PATIENTS WITH CHRONIC HEPATITIS C (CHC)",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF38": {
            "ref_id": "b38",
            "title": "Policlinico Umberto I Hospital",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Adolfo",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Attili",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF48": {
            "ref_id": "b48",
            "title": "IS IT RELATED TO RIBAVIRIN MUTAGENIC PROPERTIES INDUCING ?ERROR CATASTROPHE? Jean-Michel Pawlotsky, Rozenn Brillet, Christophe Hezode, Daniel Dhumeaux",
            "authors": [
                {
                    "first": "Mechanisms",
                    "middle": [],
                    "last": "Of",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Early Antiviral",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "In",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Hepatitis C",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF59": {
            "ref_id": "b59",
            "title": "NJ # 1197 INCIDENCE, RISK FACTORS AND TREATMENT OF MOOD DISORDERS ASSOCIATED WITH PEGINTERFERON AND RIBAVIRIN THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C : RESULTS OF A PROSPECTIVE STUDY Laurent Castera, H6pital Haut Ldv~que",
            "authors": [
                {
                    "first": "Cedars-Sinai Medical",
                    "middle": [],
                    "last": "Graham M Woolf",
                    "suffix": ""
                },
                {
                    "first": "Los",
                    "middle": [],
                    "last": "Center",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Angeles",
                    "suffix": ""
                },
                {
                    "first": "Columbia-Presbyterian Medical",
                    "middle": [],
                    "last": "Ca; Robert S Brown",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Center",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Guillaume Sauv6, Victor de Ledinghen, H6pital Haut LdvQque",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF64": {
            "ref_id": "b64",
            "title": "Children's Department, Helios Klinikum, Wuppertal, Germany # 1202 COMPARISON OF LOW DOSE WITH STANDARD DOSE PEG-INTERFERON ALFA-2B PLUS RIBAVIRIN FOR INITIAL",
            "authors": [
                {
                    "first": "Peg-Interferon-Alpha-2b And",
                    "middle": [],
                    "last": "Ribavirin",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "In",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "With",
                    "suffix": ""
                },
                {
                    "first": ";",
                    "middle": [],
                    "last": "Hepatitis C Stefan Wirth",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Of",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Hepatits C Edward",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Krawitt",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Heidrun Pieper-Boustani",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF66": {
            "ref_id": "b66",
            "title": "Gastro-Biliary Association",
            "authors": [
                {
                    "first": "Alan",
                    "middle": [],
                    "last": "Sheinbaum",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Robert",
                    "suffix": ""
                },
                {
                    "first": "Concord",
                    "middle": [],
                    "last": "Thomson",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Gastroenterology",
                    "suffix": ""
                },
                {
                    "first": "Nh; Sam",
                    "middle": [],
                    "last": "Concord",
                    "suffix": ""
                },
                {
                    "first": "Liviu",
                    "middle": [],
                    "last": "Moskowitz",
                    "suffix": ""
                },
                {
                    "first": ";",
                    "middle": [],
                    "last": "Schapira",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "James",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Corsanti",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Digestive Health Physicians",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF71": {
            "ref_id": "b71",
            "title": "H6pital Beaujon",
            "authors": [
                {
                    "first": "Frangoise",
                    "middle": [],
                    "last": "Degos",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Beaujon",
                    "suffix": ""
                },
                {
                    "first": "France; Delphine",
                    "middle": [],
                    "last": "Clichy",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Dargere",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Cnrs",
                    "suffix": ""
                },
                {
                    "first": "France; Nanou",
                    "middle": [],
                    "last": "Paris",
                    "suffix": ""
                },
                {
                    "first": "Jacques",
                    "middle": [],
                    "last": "Pham",
                    "suffix": ""
                },
                {
                    "first": "Claude",
                    "middle": [],
                    "last": "Belghiti",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Degott",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF74": {
            "ref_id": "b74",
            "title": "# 1231 SOLUBLE GLYPICAN-3 (SGPC3)",
            "authors": [
                {
                    "first": "Identified By Genome-Wide Analysis Of Gene-Expression Profiles Using Oligonucleotide",
                    "middle": [],
                    "last": "Microarray",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Is A Candidate",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Of Biomarker For",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "To",
                    "suffix": ""
                },
                {
                    "first": "Yutaka",
                    "middle": [],
                    "last": "Differentiated Hepatocellular Carcinoma Kiyotaka Watanabe",
                    "suffix": ""
                },
                {
                    "first": "Hiroshi",
                    "middle": [],
                    "last": "Midorikawa",
                    "suffix": ""
                },
                {
                    "first": "Yoshitaka",
                    "middle": [],
                    "last": "Kanamori",
                    "suffix": ""
                },
                {
                    "first": "Akira",
                    "middle": [],
                    "last": "Hippo",
                    "suffix": ""
                },
                {
                    "first": "Shin",
                    "middle": [],
                    "last": "Watanabe",
                    "suffix": ""
                },
                {
                    "first": "Tatsuhiko",
                    "middle": [],
                    "last": "Ohnishi",
                    "suffix": ""
                },
                {
                    "first": "Masatoshi",
                    "middle": [],
                    "last": "Kodama",
                    "suffix": ""
                },
                {
                    "first": "Hiroyuki",
                    "middle": [],
                    "last": "Makuuchi",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Aburatani",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF75": {
            "ref_id": "b75",
            "title": "VALIDATION STUDY OF THE NEW PROGNOSTIC STAGING SYSTEM, THE JAPAN INTEGRATED STAGING SCORE (JIS SCORE) FOR HEPATOCELLULAR CARCINOMA IN 3,934 JAPANESE PATIENTS: A MULTICENTER COLLABORATIVE STUDY",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF80": {
            "ref_id": "b80",
            "title": "Addenbrooke's Hospital",
            "authors": [
                {
                    "first": "Graeme",
                    "middle": [],
                    "last": "Alexander",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF83": {
            "ref_id": "b83",
            "title": "HOMOZYGOSITY FOR THE ALCOHOLDEHYDROGENASE 3\"1 ALLELE IS ASSOCIATED WITH HEPATOCELLULAR CARCINOMA IN ALCOHOL-INDUCED CIRRHOSIS Felix Stickel",
            "authors": [
                {
                    "first": "Michael",
                    "middle": [],
                    "last": "Olausson",
                    "suffix": ""
                },
                {
                    "first": "Lars",
                    "middle": [],
                    "last": "Backman",
                    "suffix": ""
                },
                {
                    "first": "Sahlgrenska",
                    "middle": [],
                    "last": "Hospital",
                    "suffix": ""
                },
                {
                    "first": "Sweden; Bent",
                    "middle": [],
                    "last": "Gothenburg",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Hansen",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Rigshospitalet",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Copenhagen",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Denmark; Erik",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Schrumpf",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Rikshospitalet",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Oslo",
                    "suffix": ""
                },
                {
                    "first": "Bo-G6ran",
                    "middle": [],
                    "last": "Norway; Antti Oksanen",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Ericzon",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "METABOLISM AND EXCRETION OF [14C]HEPAVIR B AND [14C]HEPSERA IN RATS AND MONKEYS Chin-Chung Lin, Li-Tain Yeh, Christine Xu, Yifei Liu, Nanqun Zhu, Ribapharm, Inc., Costa Mesa, CA # 1194 END OF TREATMENT AND SUSTAINED RESPONSE TO PEGINTERFERON ALFA-2A (40KD) (PEGASYS) PLUS RIBAVIRIN (RBV) (COPEGUS) AND AMANTADINE (AMA), AND TO INDUCTION THERAPY WITH INTERFERON (IFN) ALFA-2A (ROFERON-A) PLUS RBV AND AMA IN IFN",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "CHARACTERIZATION OF THE FUNCTIONAL DOMAIN IN HEPATITIS C VIRUS NS2 PROTEIN THAT MEDIATE REPRESSION OF CELLULAR AND VIRAL GENE TRANSCRIPTIONAL ACTIVITY Annette von dem Bussche, Jack Wands, Ji Su Li, Liver Research Center, RI Hospital and Brown Medical School, Providence, RI # 407 IL-12 GENE POLYMORPHISM AND OUTCOME OF HCV INFECTION Annwyne Houldsworth, Magdalena Metzner, Peninsula Medical School, Plymouth, UK; Siegbert Rossol' Rtisselsheim Hospital, R/Jsselsheim, Germany; Ed Kaminski, Derriford Hospital, Plymouth, UK; Andy G Demaine, Matthew E Cramp, Peninsula Medical School, Plymouth, UK HEPATITIS C VIRUS CORE PROTEIN INHIBITS DEOXYCHOLIC ACID-INDUCED APOPTOSIS IN SPITE OF INDUCING OXIDATIVE STRESS Yuh-ichi Hara, Keisuke Hino, Michiari Okuda, Takakazu Furutani, Akira Kitase, Yuhki Yamaguchi, Yamaguchi University, Ube-Yamaguchi, Japan; Kui Li, University of Texas, Galveston, TX; Michael Beard, University of Adelaide, Adelaide, Australia; Steven A Weinman, Stanley M Lemon, University of Texas, Galveston, TX; Kiwamu Okita, Yamaguchi University, Ube-Yamaguchi, Japan #409 DIFFERENTIAL MECHANISM OF INTERFERON-INDUCED AND SPONTANEOUS CLEARANCE OF HEPATITIS C VIRUS INFECTION David E Kaplan, Kazushi Sugimoto, Fusao Ikeda, Jason Stadanlick, Kirti Shetty, K Rajender Reddy, Barbara Rensman, Mary Valiga, Kyong-Mi Chang, University of Pennsylvania, Philadelphia, PA GENE EXPRESSION PROFILING OF LIVER FIBROSIS IN PATIENTS WITH HEPATITIS C VIRUS CHRONIC INFECTION USING A LARGE SCALE REAL-TIME RT-PCR APPROACH Tarik Asselah, F6d6ration d'H6pato-Gastroent6rologie et INSERM U481, H6pital Beaujon, Clichy, France; Ivan Bieche, Ingrid Laurendeau, Laboratoire de G6n6tique Mol6culaire, EA 3618, Facult6 de Pharmacie, Paris, France; Claude Degott, Service d'Anatomie Pathologique, Hapital Beaujon, Clich~ France; Dominique Vidaud, Laboratoire de G6n6tique Mol6culaire, EA 3618, Facult6 de Pharmacie, et Service de Biochimie, H6pital Beaujon, Clichy, France; Fran~oise Degos, Patrick Marcellin, F6d6ration d'H6pato-Gastroent6rologie et INSERM U481, Hapital Beaujon, Clichy, France; Michel Vidaud, Laboratoire de G6n6tique Mol6culaire, EA 3618, Facult6 de Pharmacie, et Service de Biochimie, H6pital Beaujon, Clich)4 France ACUTE HEPATITIS C INFECTION FOLLOWING PATELLAR TENDON TRANSPLANTATION: IMMUNOLOGIC CORRELATES OF RECOVERY Ian A Tester, Susan Smyk-Pearson, Susan Dean, Hugo R Rosen, Portland VA Medical Center, Portland, OR Marwan S Abouljoud, Atsushi Yoshida, Dilip Moonka, Daniel if) ~) Croteau, David McVinnie, Rajinder Sharma, Kimberly Brown, Henry Ford Hospital, Detroit, MI",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "Cell Biology of Hepatic Blood Flow and Portal HypertensionTHE ROLE OF AKT IN REGULATION OF SMOOTH MUSCLE ALPHA-ACTIN PROTEIN EXPRESSION IN INJURED LIVER Songling Liu, Don C Rocke~ Duke University, Durham, NC ESTROGEN UPREGULATES NITRIC OXIDE PRODUCTION VIA ESTROGEN RECEPTOR ALPHA OF HEPATIC SINUSOIDAL ENDOTHELIAL CELLS IN CIRRHOSIS Masaharu Sakamoto, Toru Nakamura, Takuji Torimura, Ryuichiro Sakata, Osamu Hashimoto, Takato Ueno, Michio Sata, Kurume University School of Medicine, Kurume, Japan #492 A FUNCTIONAL LINK BETWEEN ENDOTHELIN B RECEPTORS AND ENOS MAINTAINS TISSUE OXYGENATION IN NORMAL LIVER Markus Paxian, University of North Carolina at Charlotte, Charlotte, NC; Steve Keller, Toan T Huynh, Carolinas Medical Center, Charlotte, NC; Mark G Clemens, University of North Carolina at Charlotte, Charlotte, NC NITROTYROSINE AND NITRIC OXIDE SYNTHASE IN THE BRAIN OF RATS WITH AMMONIA-INDUCED BRAIN EDEMA Javier Vaquero, Michael E Cahill, Chuhan Chung, Andres T Blei, Lakeside VA Medical Center and Northwestern University, Chicago, IL #494 AUGMENTED TNFALPHA (TNF) EXPRESSION BY ACTIVATED MONOCYTES AND ALTERED T-CELL HOMEOSTASIS IN ASCITIC CIRRHOSIS: AMELIORATION WITH NORFLOXACIN Agustin Albillos, Hospital Ramon y Cajal, CIB-CSIC, Universidad Alcala, Madrid, Spain; Antonio De-la-Hera, Eduardo Reyes, Jorge Monserrat, Leticia Mufioz, Monica Nieto, CIB-CSIC, Universidad Alcala, Madrid, Spain; Luis Ruiz-del-Arbol, Hospital Ramon y Cajal, Universidad Alcala, Madrid, Spain; Eva Sanz, CIB-CSIC, Universidad Alcala, Madrid, Spain; Melchor Alvarez-Mon, Hospital Principe Asturias, CIB-CSIC, Universidad Alcala, Madrid, Spain INTRAPULMONARY VASCULAR DILATATION AND NITRIC OXIDE IN HYPOXEMIC RATS WITH CHRONIC BILE DUCT LIGATION Xue-Jun Zhang, Yasumi Katsuta, Toshio Akimoto, Masaru Ohsuga, Yoshihito Kato, Takamichi Nagato, Shuji Shimizu, Hirokazu Komeichi, Katsuaki Satomura, Takumi Aramaki, Nippon Medical School, Tokyo, Japan ENHANCED ETB RECEPTOR MEDIATED VASODILATATION IN RESPONSE TO ET-1 IN PULMONARY ARTERY SEGMENTS FROM ANIMALS WITH PREHEPATIC PORTAL HYPERTENSION AND EXPERIMENTAL HPS Daisheng Song, David Ku, University of Alabama at Birmingham, Birmingham, AL; Michael B Fallon, University of Alabama at Birmingham and Birmingham VA Medical Center, Birmingham, AL HCC and Cholangiocarcinoma: Experimental #497 TRANSACTIVATION-DEFICIENT ONCOGENIC DELTATA-P73 AND DN-P73 PROTEINS ARE OVEREXPRESSED IN HCCS Emanuele Palescandolo, Stefania Vossio, Antonio Costanzo, Marcella Fulco, Massimo Levrero, Fondazione Andrea Cesalpino, Rome, Italy; Clara Balsano, University of UAquila, UAquila, Italy ANTIDIABETIC THIAZOLIDINEDIONES INHIBIT HEPATIC TUMOR FORMATION IN HBV TRANSGENIC MOUSE MODEL Elisabetta Ceni, University of Florence, Firenze, Italy; David W Crabb, Indiana University, Indianapolis, IN; Tommaso Mello, University of Florence, Firenze, Italy; Erica Villa, Filippo Schepis, University of Modena, Modena, Italy; Marco Tarocchi, Maria R Biagini, Chiara Corrado, Alessandro Casini, Stefano Milani, Calogero Surrenti, Galli Andrea, University of Florence, Firenze, italy RHO-KINASE INHIBITOR SUPPRESSES TUMOR GROWTH AND INTRAHEPATIC METASTASES OF HEPATOCELLULAR CARCINOMA--IN VITRO AND IN VIVO STUDY Feng Xue, Terumi Takahara, Kazunobu Nonome, Yutaka Yata, Eiji Shinno, Akiharu Watanabe, Toyama Medical and Pharmaceutical University, Toyama City, Japan THE ROLE OF THE EXTRACELLULAR MATRIX IN THE DEVELOPMENT OF COLORECTAL CANCER LIVER METASTASES John A Conti, Chris Benyon, University of Southampton, Southampton, UK; John N Primrose, University of Southampton, Southampton, UK; John P Iredale, University of Southampton, Southampton, UK HCV CORE-El-E2 ACTS AS AN HCC TUMOR ACCELERATOR THROUGH SUPPRESSION OF APOPTOSIS Yoshitaka Kamegaya, Yoichi Hiasa, Lawrence Zukerberg, Nina Fowler, Jason Blackard, Wenyu Lin, Emmett Schmidt, Raymond T Chung, Massachusetts General Hospital, Boston, MA Travel Award Recipient Hospital General de Valencia, Valencia, Spain; Albert Tran, H6pital de l'Archet' Nice, France; Paul Pockros, The Scripps Clinic, La Jolla, CA; Robert Reindollar, Carolinas Center for Liver Disease, Charlotte, NC; Daniele Prati, IRCCS Maggiore Hospital, Milan, Italy; Frangois Lamour, Pilar Lardelli, Roche Diagnostics, Basel, Switzerland; Stefan Zeuzem, Saarland University Hospital, Homburg/Saar, Germany QUANTITATION OF HCV POSITIVE-AND NEGATIVE-STRAND RNA IN LIVER TISSUE BY STRAND-SPECIFIC TAQMAN REAL-TIME PCR ASSAYS Lan Lin, Marc Van Ranst' Jos Van Pelt, Frederik Nevens, Johan Fevery, Chris Verslype, UZ Gasthuisberg, Leuven, Belgium # 570 STAGING OF LIVER FIBROSIS ESTIMATED BY HISTOLOGIC ANALYSIS OF LIVER TISSUE VS COMPUTER ANALYSIS OF DIGITALIZED LIVER IMAGES IN PATIENTS WITH CHRONIC HEPATITIS C Araby A Nacul, UPF/UFRGS, Passo Fundo, Brazil; Hugo Cheinquer, UFRGS/FFFCMPA, Porto Alegre, Brazil; Carlos T Cersky, UFRGS, Porto Alegre, Brazil; Vinicius Duval, PUCRS, Porto Alegre, Brazil Denotes AASLD Presidential Poster of Distinction Hepatitis C: Epidemiology and Natural History INFECTION OF PRIMARY HUMAN MACROPHAGES WITH HEPATITIS C VIRUS IN VITRO: INDUCTION OF TUMOR NECROSIS FACTOR ALPHA AND INTERLEUKIN 8 Tomasz Laskus, Marek Radkowski, Mayo Clinic Scottsdale, Scottsdale, AZ; Marek Nowicki, University of Southern California, Los Angeles, CA; Jeffrey Wilkinson, Debra M Adair, Mayo Clinic Scottsdale, Scottsdale, AZ; Andrzej Horban, Municipal Hospital of Infectious Diseases, Warsaw, Poland; Jorge Rakela, Mayo Clinic Scottsdale, Scottsdale, AZ # 547 HOST-VIRUS INTERACTIONS IN ACUTE HEPATITIS C Kazushi Sugimoto, David E Kaplan, Fusao Ikeda, Jason Stadanlick, Gina Suh, University of Pennsylvania and Philadelphia VA Medical Center, Philadelphia, PA; Ayse Aytaman, Brooklyn VA Medical Center, Brooklyn, NY; Michael Luce~ University of Wisconsin, Milwaukee, WI; Stuart Ray, Johns Hopkins University, Baltimore, MD; Frederick Nunes, Pennsylvania Hospital, Philadelphia, PA; K Rajender Reddy, University of Pennsylvania, Philadelphia, PA; Kyong-Mi Chang, University of Pennsylvania and Philadelphia VA Medical Center, Philadelphia, PA USE OF NUCLEOTIDE SEQUENCE ANALYSIS OF THE NS5B REGION FOR ROUTINE GENOTYPING OF HEPATITIS C VIRUS : IDENTIFICATION OF NUMEROUS VARIANTS NOT CLASSIFIABLE INTO THE KNOWN HCV GENOTYPES Donald Murphy, INSPQ--Laboratoire de Sant6 Publique du Qu6bec, Montr6al, PQ, Canada; Bernard Willems, CHUM-H6pital Saint-LuG Montr6al, PQ, Canada; Marc Desch6nes, CUSM--H6pital Royal Victoria, Montr6al, PQ, Canada; Nir Hilzenrat, H6pital G6n6ral Juif, Montr6al, PQ, Canada; Roger Mousseau, H6pital Maisonneuve-Rosemont, Montr6al, PQ, Canada HEPATITIS C IN 2,410 PATIENTS 65 YEARS OR OLDER. A SEVERE AND NEGLECTED CURABLE DISEASE? Dominique Thabut, Sophie Le Calvez, Vincent Thibault, Julien Massard, Cecilia d'Arondel, Joseph Moussalli, Mona Munteanu, Vincent Di Martino, Yves Benhamou, Vlad Ratziu, Thierry Poynard, Groupe Hospitalier Pitie-Salpetriere, Paris, France HEMOPHILIC SIBLINGS WITH CHRONIC HEPATITIS C: EVIDENCE OF A GENETIC ASSOCIATION WITH DISEASE PROGRESSION Michael W Fried, University of North Carolina, Chapel Hill, NC; Barbara L Kroner, Liliana R Preiss, Research Triangle Institute, Rockville, MD; Dickens Theodore, University of North Carolina, Chapel Hill, NC; James J Goedert, National Cancer Institute, Rockville, MD PROJECTING THE PROGNOSIS OF HEPATIC FIBROSIS IN HIV-HCV CO-INFECTION John B Wong, Barbara McGovern, Tufts-New England Medical Center, Boston, MA; Mark S Sulkowski, Johns Hopkins University, Baltimore, MD; Douglas T Dieterich, Mount Sinai Medical Center, New York, NY; Thierry Poynard, Groupe Hospitalier Pitie Salpetriere, Paris, France COMPARING THE PUBLIC HEALTH BURDEN OF CHRONIC HEPATITIS C AND HIV INFECTION IN UNITED STATES Sylvie Deuffic-Burban, INSERM U444, Paris, France; John B Wong, Tufts-New England Medical Center, Boston, MA; Thierry Poynard, Groupe Hospitalier Pitie Salpetriere, Paris, France HISTOLOGIC-HEMODYNAMIC CORRELATIONS IN HEPATITIS C AND OTHER CHRONIC LIVER DISEASES--IS THERE A HISTOLOGICALLY MILD AND SEVERE CIRRHOSIS? Satish Nagula, Dhanpat Jain, Yale University School of Medicine, New Haven, CT; Roberto J Groszmann, Guadalupe Garcia-Tsao, Yale University School of Medicine, CT-VA Healthcare System, New Haven-West Haven, CT THE USEFULNESS OF A NEW IMMUNO-RADIOMETRIC ASSAY TO DETECT HEPATITIS C CORE ANTIGEN IN A COMMUNITY-BASED POPULATION Kazunori Kusumoto, Katsuhiro Hayashi, Hirohumi Uto, Satoru Hasuike, Keiko Toyama, Kenji Nagata, Takeshi Hori, Akihiko Okayama, Hirohito Tsubouchi, Miyazaki Medical College, Miyazaki, Japan; Sherri O Stuver, Boston University School of Public Health, Boston, MA #555 IMPROVED DETECTION OF ACTIVE HEPATITIS C VIRUS INFECTION IN CADAVER DONORS USING TRANSCRIPTION MEDIATED AMPLIFICATION ASSAY Claudia Chinchilla, Livier A Corado, Sali Aswad, National Institute of Transplantation, Los Angeles, CA; Tom Moone, One Legac~ Los Angeles, CA; Robert Mendez, Rafael Mendez, Nasreen S Khan, National institute of Transplantation, Los Angeles, CA #556 ENVIRONMENTAL STABILITY OF HEPATITIS C VIRUS (HCV): VIABILITY OF DRIED/STORED HCV IN CHIMPANZEE INFECTIVITY STUDIES Kris Krawczynski, Miriam J Alter, Betty H Robertson, Ling Lu, John E Spelbring, Karen A McCaustland, Centers for Disease Control and Prevention, Atlanta, GA #557 ABSOLUTE CD4 T-CELL SUBSETS ARE DECREASED IN HIV-SERONEGATIVE PATIENTS WITH CIRRHOSIS Barbara McGovem, Marvin Lopez, Yoav Golan, Angela Lawton, Grayson Moore, Daniel Pratt, Mark Epstein, Tamsin Knox, New England Medical Center, Boston, MA PREVALENCE ESTIMATES AND RISK FACTORS FOR HEPATITIS C VIRUS RNA POSITIVITY IN A LARGE POPULATION-BASED COHORT Dana Bruden, Thomas Hennessy, Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK; Carol Christensen, Alaska Native Tribal Health Consortium, Anchorage, AK; Dan Sullivan, University of Washington School of Medicine, Seattle, WA; Chriss Homan, Alaska Native Tribal Health Consortium, Anchorage, AK; Heike Dubner, University of Washington School of Medicine, Seattle, WA; Michael Bruce, Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK; Steve Livingston, James Williams, Alaska Native Tribal Health Consortium, Anchorage, AK; David Gretch, University of Washington School of Medicine, Anchorage, AK; Brian McMahon, Alaska Native Tribal Health Consortium; Arctic investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK HETEROGENEITY OF INTRAHEPATIC ARTERIO-PORTAL BLOOD MIXING STUDIED BY 13N-AMMONIA PET OF INTACT PIG LIVER Susanne Keiding, Ole L Munk, Hendrik Vilstrup, Aarhus University Hospital, Aarhus, Denmark; Ludvik Bass, University of Queensland, Aarhus, Australia #533 FACTOR V LEIDEN (FVL) MUTATION IN CHILDREN WITH PORTAL VEIN THROMBOSIS Hanaa E1-Karaksy, Mortada A1-Shabrawi, Nehal E1-Koofy, Manal E1-Hawar)~ Azza Mostafa, Marwa Safy, Mona Aziz, Manal Wilson, Hala Ali, Afaf E1-Guizery, Cairo University, Cairo, Egypt; Hassan H A-Kader, University of Arizona, Tucson, AZ Massimo Pozzi, Clinica Medica, Azienda Ospedaliera San D O Gerardo, Universith degli Studi Milano-Bicocca, Monza, Italy; if) O Guido Grassi, Laura Ratti, Clinica Medica, Monza, Italy; Giorgio VARIATIONS OF ASSAY COMPONENTS ON FIBROTEST AND ACTITEST RESULTS. TRANSFERABILITY OF ASSAY RESULTS ON DIFFERENT AUTOMATS IN THE SAME LABORATORY Fran~oise Imbert-Bismut, Djamila Messous, Asma Srairi, Rachel Morra, Mona Munteanu, Anne S Guibert, Dominique Thabut, Vincent Thibaut, Annie Piton, Bernard Hainque, Thierry Poynard, Groupe Hospitalier Pitie-Salpetriere, Paris, France SEQUENCE ANALYSIS OF BSEP AND MDR3 IN PATIENTS WITH INTRAHEPATIC CHOLESTASIS OF PREGNANCY Christiane Pauli-Magnus, Yvonne Meier, University of Zfirich, ZCirich, Switzerland; Reinhold Kerb, Epidauros AG, Bernried, Germany; Tina Zodan-Marin, University of Zi.irich, Z/Jrich, Switzerland; Thomas Lang, Epidauros AG, Bernried, Germany; Beat Mfillhaupt, Rolf Zimmermann, Peter J Meier, Gerd A Kullak-Ublick, University of ZCirich, Zfirich, Switzerland # 754 THE ONTOGENY OF CD10 EXPRESSION BY HEPATOCYTES AND ITS CLINICAL IMPLICATIONS FOR PLASMA NEUTRAL ENDOPEPTIDASE ACTIVITY AS A MARKER OF CHOLESTASIS N J Meara, J A Byrne, A C Rayner, R J Thompson, A S Knisely, King's College Hospital, London, UK # 755 DEVELOPMENTAL OUTCOME OF EXTRAHEPATIC BILIARY ATRESIA INFANTS WITH FAILED AND WORKING KASAI PORTOENTEROSTOMIES Michael Balthazor, Vicky Lee Ng, Lina Barkas, Eve A Roberts, Hospital for Sick Children, Toronto, ON, Canada # 756 BILIARY ATRESIA SPLENIC MALFORMATION SYNDROME; A SINGLE CENTER EXPERIENCE OVER 25 YEARS Sarah Tizzard, Nedim Hadzic, hlstitute of Liver Studies, King's College Hospital, London, UK; Mark Davenport, Dept of Paediatric Surger~ London, UK; Edward R Howard, Institute of Liver Studies, London, UK; Anil Dhawan, Alastair J Baker, Giorgina Mieli-Vergani, Institute of Liver Studies, King's College Hospital, London, UK # 757 BILIARY OBSTRUCTION IMPAIRS RED CELL OXIDATIVE CAPACITY Ibrahim E1 Sayed, Ibrahim E1 Kady, Genetic Engineering Institute, Menoufiya University, Shebeen E1-Kom, Egypt; Gamal Badra, Imam Waked, National Liver Institute, Shebeen E1-Kom, Egypt # 758 UPREGULATION OF A TH1 INFLAMMATORY CYTOKINE OSTEOPONTIN IN PATIENTS WITH BILIARY ATRESIA: DIFFERENTIAL LOCALIZATION AT DIAGNOSIS AND AT TRANSPLANT Peter F Whitington, Padmini Malladi, Hector Melin-Aldana, Northwestern University, Chicago, IL; Cara L Mack, University of Colorado, Denver, CO; Atul Sahai, Northwestern University, Chicago, IL Viral Hepatitis and Liver Transplantation # 759 OUTCOME OF LIVER TRANSPLANTATION FOR HEPATITIS B IN THE U.S W Ray Kim, John J Poterucha, Michael B Ishitani, E Rolland Dickson, Mayo Clinic and Foundation, Rochester, MN # 760 FATAL CRYPTOGENIC LIVER DISEASE AFTER SUSTAINED ERADICATION OF RECURRENT HEPATITIC C IN LIVER TRANSPLANTATION Sandeep Mukherjee, Richard K Gilroy, Joyce Rogge, Lynne Weaver, Timothy M McCashland, Daniel F Schafer, University of Nebraska Medical Center, Omaha, NE Denotes AASLD Presidential Poster of Distinction # 732 GENDER DIFFERENCES IN HEPATIC GENE EXPRESSION OF PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) Francesco Gorreta, Luca Del Giacco, Karen Schlauch, Amy VanMeter, Geraldine Grant, Alan Christensen, Vikas Chandhoke, George Mason University, Manassas, VA; Zachary Goodman, Armed Forces Institute of Pathology, Washington, DC; Abraham Younoszai, Hazem Elarin?; Janus P Ong, Zobair M Younossi, Center for Liver Diseases, inova Fairfax Hospital Falls Church, VA # 733 A BEHAVIORAL ANALYSIS OF NONALCOHOLIC FATTY LIVER DISEASE: IMPLICATIONS FOR THE CLINICIAN Deborah L Hailer, Carol Sargeant, Velimir A Luketic, Melissa J Contos, Richard Sterling, Mitchell L Shiffman, Richard T Stravitz, Arun J Sanyal, Virginia Commonwealth University, Richmond, VA # 734 DIETARY COMPOSITION AND FATTY LIVER DISEASE Amir R A A1-Khuraishi, Steven F Solga, Jeanne M Clark, Michael Torbenson, Ashli Cohen, Anna Mae Diehl, Thomas H Magnuson, Johns Hopkins University, Baltimore, MD # 735 SERUM LEPTIN LEVELS IN NONALCOHOLIC FATTY LIVER DISEASE: RESULTS FROM THE THIRD NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY (NHANES III) Suthat Liangpunsakul, Naga Chalasani, Indiana University School of Medicine, Indianapolis, IN # 736 THE UTILITY OF IMMUNOSTAINING FOR MALLORY BODIES IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) Anupamjit Mehrotra, Zachary Goodman, Armed Forces hlstitute of Pathology, Washington, DC; Hazem Elariny, Janus P Ong, Abraham Younoszai, Navdeep BoparaL Jennifer Assmann, Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, VA; Vikas Chandhoke, George Mason University, Manassas, VA; Zobair M Younossi, Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, VA # 737 DIAGNOSIS OF NASH USING KUPFFER IMAGING OF CONTRAST ENHANCED ULTRASOUND Hiroko Iijima, Fuminori Moriyasu, Tokyo Medical University, Tokyo, Japan; Kaoru Tsuchiya, Musashino Red Cross Hospital, Tokyo, Japan; Shunichi Sasaki, Shiro Suzuki, Toshiya Horibe, Tokyo Medical University, Tokyo, Japan PBC/PSC and Complications of Cholestasis # 738 HIGH PREVALENCE OF PROTEIN C DEFICIENCY IN PRIMARY SCLEROSING CHOLANGITIS Bertrand Condat, H6pital Beaujon, Clichy, France; Olivier Chazouill6res, H6pital Saint Antoine, Paris, France; Dermot O'Toole, Marie-Hdl6ne Denninger, Camille Barreau, Marie-Pierre Vuillerme, Marie-Pierre Ripault, H6pital Beaujon, Clichy, France; ZaTr Hassani, H6pital Saint Louis, Paris, France; Annie Robert, H6pital Saint Antoine, Paris, France; Pierre Ruffat, Annie Bezeaud, Yann Consigny, H6pital Beaujon, Clichy, France; Yann Ngo, H6pital Saint Camille, Bry sur Marne, France; Nathalie Goutte, H6pital Beaujon, Clichy, France; Marc Leman, H6pital Saint Louis, Paris, France; Philippe Ruszniewski, Dominique Valla, H6pital Beaujon, Clichy, France # 739 PROTEASOME IS REQUIRED FOR CLASS I-RESTRICTED PRESENTATION BY FC GAMMA RECEPTOR-MEDIATED ENDOCYTOSIS IN PRIMARY BILIARY CIRRHOSIS Hiroto Kita, University of California Davis, Davis, CA; Aftab A Ansari, Emory University School of Medicine, Atlanta, GA; Xiao-Song He, Zhe-Xiong Lian, Judy Van de Water, University of California Davis, Davis, CA; Ross L Coppel, Monash University, Melbourne, Australia; Velimir Luketic, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA; Marshall M Kaplan, New England Medical Center, Boston, MA; Hideaki Inamori, Norio Isoda, Kentaro Sugano, Jichi Medical School, Yakushiji, Japan; Michio Imawari, Omiya Medical Center, Jichi Medical School Saitama, Japan; M Eric Gershwin, University of California Davis, Davis, CA # 740 PLACEBO-CONTROLLED TRIAL OF VITAMIN K SUPPLEMENTATION ON BONE MINERAL DENSITY IN PRIMARY BILIARY CIRRHOSIS(PBC) Dermot Gleeson, Sheffield Teaching Hospitals, Sheffield, UK; Stephen Hodges, University of Sheffield, Sheffield, UK; Elizabeth Rigney, Sheffield Teaching Hospitals, Sheffield, UK; Aubrey Blumsohn, Rosemary Hannon, Nicola F A Peel, Richard Eastell, University of Sheffield, Sheffield, UK # 722 LOCALIZATION OF OXIDIZED PHOSPHATIDYLCHOLINE IN (9 STEATOTIC LIVERS; ITS RELATION TO OXIDATIVE INJURY ~ IN FATTY LIVER DISORDERS Yoshihiro Ikura, Masahiko Ohsawa, Yoshihiko Ogawa, Kazuhisa a Z I11 Kaneda, Eishu Hai, Soichiro Kayo, Noriko Yoshimi, Nobuyuki D O Shirai, Yoshimi Sugama, Hiroko Fujino, Osaka City University Heneghan, Michael L Allan, Jeffrey D Bornstein, Andrew J Muir, David A Tendler, Duke University Medical Center, Durham, NC # 683 MYCOPHENOLATE MOFETIL IMPROVES LIVER TESTS IN PATIENTS WITH AUTOIMMUNE HEPATITIS (AIH) Atoya Adams, Robert Gish, Ed Wakil, Natalie Bzowej, Ed Doo, Maurizio BonacinL California Pacific Medical Center, San Francisco, CA # 684 CLINICAL CHARACTERISTICS AND LONG-TERM O PROGNOSIS OF AUTOIMMUNE HEPATITIS (AIH) / PRIMARY O (j) SCLEROSING CHOLANGITIS (PSC) OVERLAP-SYNDROME ~) C Stefan Ltith, Stephan Kanzler, Anna Vieth, University Hospital of ill Z Mainz, Mainz, Germany; Hans P Dienes, University Hospital of ~/1 ~. Cologne, Mainz, Germany; Peter R Galle, Ansgar W Lohse, rO -K University Hospital of Mainz, Mainz, Germany 0~ # 685 ADOPTIVE TRANSFER OF NKT CELLS ALLEVIATES GRAFT VERSUS HOST DISEASE AND IMPROVES SURVIVAL IN A MURINE MODEL OF SEMI-ALLOGENEIC BONE MARROW TRANSPLANTATION: THE ROLE OF THE LIVER IN TOLERANCE INDUCTION Maya Margalit, Hadassah Hebrew University Medical Center, Jerusalem, Israel; Arnon Nagler, Chaim Sheba Medical Center, Tel Hashomer, Israel; Meir Ohana, Rifat Safadi, Ruslana Alper, Yoav Sherman, Victoria Doviner, Hadassah Hebrew University Medical Center, Jerusalem, Israel; Elazar Rabbani, Dean L Engelhardt, Enzo Biochem Inc., Framingdale, NY; Yaron Ilan, Hadassah Hebrew University Medical Center, Jerusalem, Israel # 870 MITOCHONDRIAL GLUTATHIONE UNFOLDS THE APOPTOTIC POTENTIAL OF TUMOR NECROSIS FACTOR-ALPHA (TNF) Montserrat Marl Anna Colell, Carmen Garcfa-Ruiz, Jos6 Carlos Fernelndez-Checa, Hospital Clinic, IDIBAPS, CSIC, Barcelona, Spain # 871 IDN-6556, THE FIRST ANTI-APOPTOTIC CASPASE INHIBITOR: PRECLINICAL EFFICACY AND SAFETY Niel C Hoglen, Craig D Fisher, Brad P Hirakawa, Karen L Valentino, David A Shapiro, Patricia C Contreras, Idun Pharmaceuticals, Inc., San Diego, CA TUMOR NECROSIS FACTOR (TNF)-ALFA MEDIATED APOPTOSIS IN ANTI-TUBERCULAR DRUG INDUCED HEPATOTOXICITY Abhijit Chowdhury, Institute of Post Graduate Medical Education and Research, Kolkata, India # 873 INHIBITOR OF APOPTOSIS PROTEIN-1 AND -2 MAY PROTECT HEPATOCYTES FROM APOPTOSIS INDUCED BY TUMOR NECROSIS FACTOR-ALPHA IN MICE Sumiko Nagoshi, Saitama Medical School, Saitama, Japan; Takayuki Yoshimoto, Tokyo Medical University, Tokyo, Japan; Satoshi Mochida, Kenii Fujiwara, Saitama Medical School, Saitama, Japan # 874 IDN-6556, THE FIRST ANTI-APOPTOTIC CASPASE INHIBITOR IN CLINICAL TRIALS: TISSUE DISTRIBUTION AND PHARMACOKINETICS Long-Shiuh Chen, Niel C Hoglen, Craig D Fisher, Karen L Valentino, Patricia C Contreras, Idun Pharmaceuticals, Inc., San Diego, CA EXPRESSION OF A SHORT CYCLIN E1 SPLICE VARIANT INVERSELY CORRELATES WITH CELL CYCLE PROGRESSION OF HEPATOCYTES Nils-Holger Zschemisch, Christian Liedtke, Torsten Wustefeld, Medical School of Hannover, Hannover, Germany; Roman Halter, Juergen Borlack, Fraunhofer Institute of Toxicology and Experimental Medicine, Hanover, Germany; Michael P Manns, Christian Trautwein, Medical School of Hannover, Hannover, Germany IL-12 AND IFNc, GENE THERAPY FOR HEPATIC METASTASIS OF COLON CANCER: DIFFERENCE IN GENERATION OF INNATE AND ADAPTIVE IMMUNE RESPONSES Chihiro Ohnishi, Tetsuo Takehara, Takahiro Suzuki, Masahisa Jinushi, Takuya Miyagi, Tomohide Tatsumi, Naoki Hiramatsu, Tatsuya Kanto, Norio Hayashi, Osaka University Graduate School of Medicine, Suita, Osaka, Japan HEPATIC OVEREXPRESSION OF TGF-BETA 1 DURING LIVER INJURY LEADS TO MASSIVELY INCREASED IL-6 LEVELS AND HIGH MORTALITY RATES Florian R Thieringer, Jose F Garcia-Lazaro, Piotr Czochra, Diana Friebe, Erik Meyer, Stefan Lfith, Marcus Schuchmann, Peter R Galle, Ansgar W Lohse, Stephan Kanzler, Johannes Gutenberg University, Mainz, Germany # 879 REGULATION OF 5-AMINOLEVULINATE SYNTHASE-1 BY GLUCOSE AND HEME Sridevi Kolluri, University of Connecticut Health Center, Farmington, CT; Timothy J Sadlon, Child Health Research Institute, North Adelaide, Australia; Brian K May, University of Adelaide, Adelaide, Australia; Herbert L Bonkovsky, University of Connecticut Health Center, Farmington, CT CASPASE-8 TRANSCRIPTION CAN RAPIDLY BE UPREGULATED UPON INTERFERON cz STIMULATION VIA A STAT1 DEPENDENT MECHANISM IN HUMAN HEPATOMA CELLS Christian Liedtke, Michael P Manns, Christian Trautwein, Medical School of Hannover, Hannover, Germany REGULATION OF FERROCHELATASE GENE EXPRESSION BY HYPOXIA IN HUMAN CELL LINES Yunying L Liu, Douglas A Weigent, University of Alabama at Birmingham, Birmingham, AL; Sonny O Ang, Josef T Prchal, Baylor College of Medicine, Houston, TX; Joseph R Bloomer, University of Alabama at Birmingham, Birmingham, AL # 1124 DO HYPERLIPIDEMIC PATIENTS WITH ELEVATED BASELINE LIVER ENZYMES HAVE A HIGHER RISK OF HEPATOTOXICITY FROM HMG CO-A REDUCTASE INHIBITORS (STATINS)? Naga Chalasani, Suthat Liangpunsakul, Indiana University School of Medicine, Indianapolis, IN; Michael Murray, Joseph Kesterson, Regenstrief Institute for Health Care, Indianapolis, IN; Stephen D Hall, Indiana University School of Medicine, Indianapolis, IN # 1125 HEPATOTOXICITY ASSOCIATED WITH THE ANTIRETROVIRAL THERAPY (ART) CONTAINING PROTEASE INHIBITORS (PIS) WITH OR WITHOUT PHARMACOKINETIC BOOSTING BY LOW-DOSE RITONAVIR (RTV) Mark S Sulkowski, David L Thomas, Johns Hopkins School of Medicine, Baltimore, MD; Shruti H Mehta, Johns Hopkins School of Public Health, Baltimore, MD; Richard E Chaisson, Richard D Moore, Johns Hopkins School of Medicine, Baltimore, MD # 1126 USE OF VECTOR ANALYSIS OF LIVER FUNCTION TESTS TO DETECT AN EARLY SIGNAL OF HEPATOTOXICITY OF A DRUG IN EARLY CLINICAL TRIALS Donald C Trost, Pfizer Inc, Groton, CT; James W Freston, University of Connecticut Health Center, Farmington, CT Denotes AASLD Presidential Poster of Distinction # 1127 DO OVER-THE-COUNTER ANALGESICS CONTRIBUTE TO DECOMPENSATION OF CIRRHOSIS?--A PROSPECTIVE STUDY Sakib K Khalid, Yale University, Hepatitis C Resource Center CT-VA Healthcare System, New Haven-West Haven, CT; Jill Addesa, Victor J Navarro, Yale University, New Haven, CT; Guadalupe Garcia-Tsao, Yale University, CT-VA Healthcare System, New Haven-West Haven, CT # 1128 EFFECT OF ALCOHOL CONSUMPTION ON CYP2E1 AND CYP3A ACTIVITIES IN HUMANS: INSIGHT INTO ACETAMINOPHEN HEPATOTOXICITY IN ALCOHOLICS Suthat Liangpunsakul, Christopher J Gorski, David W Crabb, Stephen D Hall, Naga Chalasani, Indiana University School of Medicine, indianapolis, IN # 1129 AN EARLY OCCURRENCE OF IGA RESPONSES AGAINST ACETALDEHYDE-MODIFIED PROTEINS IN ALCOHOL CONSUMERS Onni J Niemela, Jaana Latvala, Petra Anttila, Kimmo Jarvi, EP Central Hospital, Seinajoki, Finland # 1130 PHARMACOLOGICAL INHIBITION OF ACID CERAMIDASE SELECTIVELY SENSITIZES HUMAN LIVER TUMOR CELLS TO ANTI-CANCER DRUGS Albert Morales, Raquel Parrs, Jos6 Carlos Fem~ndez-Checa, Hospital Clfnic, IDIBAPS, CSIC, Barcelona, Spain # 1131 EFFECTIVENESS OF ASPARTATE OF ADENOSINE AS HEPATOPROTECTIVE AND ANTI-FIBROTIC AGENT AS COMPARED WITH THE PARENTAL ADENOSINE Rolando Hern~ndez-Mufioz Sr, Instituto de Fisiologfa Celular, UNAM, Mexico, Mexico # 1132 SERUM TRANSAMINASE ELEVATIONS ALONE LACK SPECI-FICITY FOR DETECTING RARE SERIOUS LIVER DISEASE John R Senior, Food and Drug Administration, Rockville, MD; Robert W Tipping, Merck Research Laboratories, Bluebell, PA # 1133 CYP2E1 ACTIVITY IN CIRRHOSIS Jean-Pierre Villeneuve, Claire Fournier, Soumeya Brachemi, Louise Trudel, H6pital Saint-Luc, Centre Hospitalier de l'Universit6 de Montr6al, Montreal, PQ, Canada # 1134 HIGH THROUGHPUT SCREENING FOR DRUG INDUCED LIVER DISEASE--INVESTIGATIVE AND PREEMPTIVE TOXICOLOGY Norman L Sussman, James H Kelly, Amphioxus Cell Technologies, Houston, TX # 1135 IMMUNOHISTOCHEMICAL ANALYSIS OF LIVER TISSUE USING ANTIBODIES TO ACETALDEHYDE ADDUCTS, IGA AND INTERLEUKIN-8 IN PATIENTS WITH ALCOHOL RELATED LIVER DISEASE (ALD) J Koskinas, Hippokration General Hospital, Athens, Greece; L RamsaN A Warn, S Howard, N Coleman, Addenbrooke's Hospital Cambridge, UK; G Kenna, St. Mary's Hospital, London, UK; G Alexander, Addenbrooke's Hospital, Cambridge, UK # 1136 REGULATION OF METHIONINE CYCLE ENZYMES IN THE MICROPIG MODEL OF ALCOHOLIC LIVER DISEASE Jesus A Villanueva, Charles H Halsted, University of California Davis, Davis, CA # 1137 ASSESSMENT OF THE DIAGNOSTIC SCALE FOR DRUG INDUCED LIVER INJURY (DILI) BY THE INTERNATIONAL CONSENSUS MEETING (ICM) AND A PROPOSAL OF ITS MODIFICATIONS Yoriyuki Takamori, Hajime Takikawa, Teikyo University School of Medicine, Tokyo, Japan; Teru Kumagi, Morikazu Onji\u00b1 Ehime University School of Medicine, Ehime, Japan; Masaaki Watanabe, Akitaka Shibata, Kitasato University East Hospital, Kanagawa, Japan; Akiko Hisamochi, Ryukichi Kumashiro, Kurume University School of Medicine, Kurume, Japan; Tadashi Ito, Yasuhide Mitsumoto, JR-West Osaka Hospital, Osaka, Japan; Astushi Nakamura, Takashi Sakaguchi, Yokohama City University School of Medicine, Kanagawa, Japan # 1138 HEPATIC CYTOCHROME P450 DECREASES THROUGH CONTINUOUS INFUSIONS OF ORGANIC NITRATES Yukiko Minamiyama, Graduate School of Medicine and Dentistry, Okayama University, Okayama, Japan; Shigekazu Takemura, Keiichi Yamasaki\u00b1 Seikan Hal, Graduate School of Medicine, Osaka City University, Osaka, Japan; Satoshi Yamamoto, Graduate School of Medicine, Osaka City University, Okayama, Japan; Michitaka Ozaki, Shigeru Okada, Graduate School of Medicine and Dentistr> Okayama University, Okayama, Japan Hepatitis B: Treatment # 1139 CHARACTERISATION AND FUNCTIONAL ANALYSIS OF HEPATITIS B VIRUS MUTANTS SELECTED IN PATIENTS WITH SEVERE HEPATITIS DURING LONG TERM LAMIVUDINE THERAPY: ROLE OF COMPENSATORY MUTATIONS IN DISEASE PROGRESSION Nadia Warner, Stephen A Locarnini\u00b1 Anna Ayres, Geoff Thompson, Ros Edwards, Vitina Sozzi, Victorian Infectious Diseases Reference Laboratory, North Melbourne, Vic, Australia; Nancy W Y Leung, Prince of Wales Hospital, Hong Kong, SAR, China; Ben Tehan, David Chalmers, Victorian College of Pharmacy, Parkville, Vic, Australia; Angeline Bartholomeusz, Victorian Infectious Diseases Reference Laboratory, North Melbourne, Vic, Australia # 1140 ANALYSIS OF HBV-SPECIFIC CYTOTOXIC T LYMPHOCYTES INCREASING IN PERIPHERAL BLOOD DURING LAMIVUDINE THERAPY Yasuteru Kondo, Tohoku University School of Medicine, Sendai\u00b1 Japan; Shinnichi Asabe, Jichi Medical School, Kamikawachi, Japan; Koju Kobayashi\u00b1 Koju Kobayashi\u00b1 Tohoku University School of Health Science, Sendai, Japan; Masaaki Shiina, National Sendal Hospital, Sendai, Japan; Yoshiyuki Ueno, Noriatsu Kanno, Koji Fukushima, Tooru Shimosegawa, Tohoku University School of Medicine, Sendal Japan #1141 COMPLETE GENOTYPIC AND PHENOTYPIC ANALYSES OF HBV MUTATIONS IDENTIFIED IN HBEAG-NEGATIVE CHRONIC HEPATITIS B PATIENTS RECEIVING 96 WEEKS OF ADEFOVIR DIPIVOXIL (ADV) Huiling Yang, Christopher Westland, William E Delaney IV, Gilead Sciences, Inc., Foster City, CA; Peter W Angus, Austin Hospital, Melbourne, Australia; Stephen A Locarnini, Victorian Infectious Diseases Reference Laboratory, North Melbourne, Vic, Australia; George Kitis, Georgios Papanikolaou Hospital, Thessaloniki, Greece; Michael Wulfsohn, Craig S Gibbs, Michael D Miller, Carol L Brosgart, Shelly Xiong, Gilead Sciences, Inc., Foster City, CA # 1142 PROPHYLACTIC AND THERAPEUTIC EFFICACY OF A DENDRITIC CELL-BASED VACCINE FOR IMMUNOSUPPRESSED NORMAL AND CHRONIC HEPATITIS B VIRUS CARRIER MOUSE Shinya Furukawa, Sk Md Fazle Akbar, Aki Hasebe, Norio Horiike, Morikazu Onji\u00b1 Ehime University School of Medicine, Ehime, Japan MB6866 (HEPAVIR B), A HEPDIRECTTM PRODRUG OF ADEFOVIR: MECHANISM OF ACTIVATION AND LIVER TARGETING Paul D van Poelje, Timothy J Colby, James M Fujitaki, K Raja Reddy, Michael C Matelich, Kathy A Senekeo, David L Linemeyer, Mark D Erion, Metabasis Therapeutics, inc., San Diego, CA # 1144 A PHASE 2 CLINICAL STUDY EVALUATING SAFETY AND EFFICACY OF HEPEX-B, A MIXTURE OF TWO HUMAN MONOCLONAL ANTIBODIES TO HBSAG IN COMBINATION WITH LAMIVUDINE IN CHRONIC HBV PATIENTS Eithan Galun, Rifat Safadi, Alla Milchem, Zvi Akerman, Yaffa Ashur, Idit Mathot, Hadassah University Hospital, Jerusalem, israel; Zobair M Younossi, Inova Fairfax Hospital, Falls Church, VA; Gerald Y Minuk, Health Sciences Centre, Winnipeg, MB, Canada; Ofer Nussbaum, Dov Terkieltaub, XTL Biopharmaceuticals Ltd., Rehovot, Israel; Neil Graham, XTL Biopharmaceuticals Inc., Durham, NC; Rachel Eren, Shlomo Dagan, XTL Biopharmaceuticals Ltd., Rehovot, Israel # 1145 LAMIVUDINE TREATMENT DURING PREGNANCY TO PREVENT PERINATAL TRANSMISSION OF HEPATITIS B VIRUS INFECTION Monika van Zonneveld, Andeltje B van Nunen, Hubert G M Niesters, Robert A de Man, Solko W Schalm, Harry L A Janssen, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands # 1146 RESPONSE TO ALPHA-INTERFERON PROLONGS SURVIVAL AND REDUCES THE RISK OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B Monika van Zonneveld, Hubert G M Niesters, Robert A de Man, Solko W Schalm, Harry L A Janssen, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands # 1147 5-YEAR FOLLOW-UP OF 998 CHRONIC HEPATITS B PATIENTS TO DETERMINE LONG-TERM SAFETY OF LAMIVUDINE AND CLINICAL CONSEQUENCES OF LAMIVUDINE-RESISTANT MUTATIONS Anna S Lok, University of Michigan, Ann Arbor, MI; Ching-Lung Lai, University of Hong Kong, Hong Kong, Hong Kong; Nancy Leung, Prince of Wales Hospital, Hong Kong, Hong Kong; Guang-Bi Yao, Jiangan-Qu Central Hospital, Shanghai, China; Zhen-Yu Cui, Ditan Hospital, Beijing, China; Eugene R Schiff, University of Miami, Miami, FL; Jules L Dienstag, Massachusetts General Hospital, Boston, MA; Jenny Heathcote, University of Toronto, Toronto, ON, Canada; Nancy R Little, Dorothea A Griffiths, Stephen D Gardner, Mary Castiglia, GSK, Research Triangle Park, NC O # 1148 VIRAL DYNAMICS MODELING INDICATES THAT THE MAJOR MECHANISM OF ACTION OF HEPEX-B AGAINST HEPATITIS B VIRUS IS ACCELERATION OF THE FREE VIRUS CLEARANCE Avidan U Neumann, Idit Feldberg, Bar-ilan University, Ramat-Gan, Israel; Rachel Eren, Shlomo Dagan, XTL Biopharmaceuticals Ltd., Rehovot, Israel # 1149 CELLULAR IMMUNE RESPONSES TO THE HEPATITIS B VIRUS POLYMERASE DECREASE DURING LONGTERM # 1191 EFFICACY OF INTERFERON ALFA-2B AND RIBAVIRIN COMBINATION THERAPY FOR THE TREATMENT OF HEPATITIS C IN PATIENTS WITH PERSISTENTLY NORMAL ALT LEVELS Edmund J Bini, Saurabh Mehandru, VA Medical Center, New York, NY # 1192 TREATMENT RATES FOR CHRONIC HEPATITIS C AFTER LIVER BIOPSY Tamer N Sargios, Radhakrishna Kalakuntla, Gopal Narasimhan, Veronika Dubrovskaya, Peter Homel, David J Clain, Henry C Bodenheimer Jr, Albert D Min, Beth Israel Medical Center, New York, NY",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": [
        {
            "text": "Those posters identified as AASLD Presidential Poster of Distinction by a ribbon icon have received review scores that place them within the top 10% of all posters. We encourage you to make them a priority as you visit the poster session. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "annex"
        }
    ]
}